Journal of Comprehensive Pediatrics

Published by: Kowsar

Liver Involvement in Iranian Children With Cystic Fibrosis: Ultrasonography and Biochemical Findings

Mehri Najafi 1 , Farnaz Najmi Varzaneh 2 , Gholamreza Khatami 1 , Ahmad Khodadad 1 , Gholamhossein Fallahi 1 , Fatemeh Farahmand 1 , Farzaneh Motamed 1 , Mehrzad Mehdizadeh 1 , Houman Alizadeh 1 , Nima Rezaei 1 , 2 , 3 and Maryam Shoaran 1 , *
Authors Information
1 Department of Pediatrics, Children’s Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, IR Iran
2 Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, IR Iran
3 Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: August 10, 2013, 4 (3); 129-33
  • Published Online: June 1, 2013
  • Article Type: Research Article
  • Received: July 18, 2012
  • Revised: February 1, 2013
  • Accepted: February 5, 2013
  • DOI: 10.17795/compreped-7304

To Cite: Najafi M, Najmi Varzaneh F, Khatami G, Khodadad A, Fallahi G, et al. Liver Involvement in Iranian Children With Cystic Fibrosis: Ultrasonography and Biochemical Findings, J Compr Ped. 2013 ; 4(3):129-33. doi: 10.17795/compreped-7304.

Copyright © 2013, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Feranchak AP. Hepatobiliary complications of cystic fibrosis. Curr Gastroenterol Rep. 2004; 6(3): 231-9[PubMed]
  • 2. Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, Hodson M, et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol. 2001; 31(1): 1-12[PubMed]
  • 3. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245(4922): 1066-73[PubMed]
  • 4. Jackson R, Pencharz PB. Transition of care between paediatric and adult gastroenterology. Cystic fibrosis. Best Pract Res Clin Gastroenterol. 2003; 17(2): 213-35[PubMed]
  • 5. Cohn JA, Strong TV, Picciotto MR, Nairn AC, Collins FS, Fitz JG. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology. 1993; 105(6): 1857-64[PubMed]
  • 6. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005; 352(19): 1992-2001[DOI][PubMed]
  • 7. Lenaerts C, Lapierre C, Patriquin H, Bureau N, Lepage G, Harel F, et al. Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors. J Pediatr. 2003; 143(3): 343-50[DOI][PubMed]
  • 8. Patriquin H, Lenaerts C, Smith L, Perreault G, Grignon A, Filiatrault D, et al. Liver disease in children with cystic fibrosis: US-biochemical comparison in 195 patients. Radiology. 1999; 211(1): 229-32[PubMed]
  • 9. Wilmott RW. Making the diagnosis of cystic fibrosis. J Pediatr. 1998; 132(4): 563-5[PubMed]
  • 10. Patriquin H, Lafortune M, Burns PN, Dauzat M. Duplex Doppler examination in portal hypertension: technique and anatomy. AJR Am J Roentgenol. 1987; 149(1): 71-6[DOI][PubMed]
  • 11. Robinson KA, Middleton WD, Al-Sukaiti R, Teefey SA, Dahiya N. Doppler sonography of portal hypertension. Ultrasound Q. 2009; 25(1): 3-13[DOI][PubMed]
  • 12. Feigelson J, Anagnostopoulos C, Poquet M, Pecau Y, Munck A, Navarro J. Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up. Arch Dis Child. 1993; 68(5): 653-7[PubMed]
  • 13. Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child. 1991; 66(6): 698-701[PubMed]
  • 14. Campbell PW, 3rd, Phillips JA, 3rd. The cystic fibrosis gene and relationships to clinical status. Semin Respir Infect. 1992; 7(3): 150-7[PubMed]
  • 15. Fallahi G, Najafi M, Farhmand F, Bazvand F, Ahmadi M, Ahmadi F, et al. The clinical and laboratory manifestations of Iranian patients with cystic fibrosis. Turk J Pediatr. 2010; 52(2): 132-8[PubMed]
  • 16. Wilschanski M, Rivlin J, Cohen S, Augarten A, Blau H, Aviram M, et al. Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics. 1999; 103(1): 52-7[PubMed]
  • 17. Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, et al. Genetic modifiers of liver disease in cystic fibrosis. JAMA. 2009; 302(10): 1076-83[DOI][PubMed]
  • 18. Corbett K, Kelleher S, Rowland M, Daly L, Drumm B, Canny G, et al. Cystic fibrosis-associated liver disease: a population-based study. J Pediatr. 2004; 145(3): 327-32[DOI][PubMed]
  • 19. Afdhal NH. Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis? Clin Chem. 2004; 50(8): 1299-300[DOI][PubMed]
  • 20. Potter CJ, Fishbein M, Hammond S, McCoy K, Qualman S. Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria? J Pediatr Gastroenterol Nutr. 1997; 25(1): 32-6[PubMed]
  • 21. Colombo C, Apostolo MG, Ferrari M, Seia M, Genoni S, Giunta A, et al. Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr. 1994; 124(3): 393-9[PubMed]
  • 22. Ling SC, Wilkinson JD, Hollman AS, McColl J, Evans TJ, Paton JY. The evolution of liver disease in cystic fibrosis. Arch Dis Child. 1999; 81(2): 129-32[PubMed]
  • 23. Lamireau T, Monnereau S, Martin S, Marcotte JE, Winnock M, Alvarez F. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol. 2004; 41(6): 920-5[DOI][PubMed]
  • 24. Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011; 10 Suppl 2-36[DOI][PubMed]
  • 25. Graham N, Manhire AR, Stead RJ, Lees WR, Hodson ME, Batten JC. Cystic fibrosis: ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology. Clin Radiol. 1985; 36(2): 199-203[PubMed]
  • 26. Quillin SP, Siegel MJ, Rothbaum R. Hepatobiliary sonography in cystic fibrosis. Pediatr Radiol. 1993; 23(7): 533-5[PubMed]
  • 27. Williams SG, Westaby D, Tanner MS, Mowat AP. Liver and biliary problems in cystic fibrosis. Br Med Bull. 1992; 48(4): 877-92[PubMed]
  • 28. Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology. 1999; 30(5): 1151-8[DOI][PubMed]
  • 29. Colombo C, Crosignani A, Apostolo MG, Marzano MT, Bettinardi N, Giunta A. Oral bile acids in cystic fibrosis-associated liver disease. J R Soc Med. 1994; 87 Suppl 21: 20-4[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments